Documentos relacionados

1. High performance liquid chromatographic determination of cox-2 inhibitor rofecoxib in human plasma.
2. Improved procedure for the the determination of rofecoxib in human plasma involving 96-well solid-phase extraction and fluorescence detection.
3. A rapid and sensitive high-performance liquid chromatography assay for rofecoxib in human serum.
4. High-performance liquid chromatographic-tandem mass spectrometric evaluation and determination of stable isotope labeled analogs of rofecoxib in human plasma samples from oral bioavailability studies.
5. Simultaneous determination of rofecoxib and celecoxib in human plasma by high-performance liquid chromatography.
6. Determination of rofecoxib in human plasma and breast milk by high-performance liquid chromatographic assay.
7. High performance liquid chromatographic determination of cyclooxygenase II inhibitor rofecoxib in rat and human plasma.
8. Derivative spectrophotometric and fluorimetric methods for determination of rofecoxib in tablets and in human plasma in presence of its photo-degradation product.
9. Monolithic silica liquid chromatography columns for the determination of cyclooxygenase II inhibitors in human plasma.
10. Development and Validation of a Reliable UHPLC-MS/MS Method for Simultaneous Quantification of Macrocyclic Lactones in Bovine Plasma.